10X Capital Venture Acquisition Corp. III

10X Capital Venture Acquisition Corp. III

VCXB
10X Capital Venture Acquisition Corp. IIIUS flagNew York Stock Exchange
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.
Business
10X Capital Venture Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to identify business opportunities in the field of consumer internet, e-commerce, software, healthcare, transportation/mobility, financial services, artificial intelligence, automation, data science, and Software-as-a-Service. The company was incorporated in 2021 and is based in New York, New York.

Company News

  • NYSE American to Commence Delisting Proceedings with Respect to the Warrants of 10X Capital Venture Acquisition Corp. III (VCXB WS)

  • 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-K Filing

  • 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Noncompliance

  • 10X Capital Venture Acquisition Corp. III Announces Expected Change in Management

  • 10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing

  • 10X Capital Venture Acquisition Corp. III Announces Transfer of Listed Securities to the NYSE American

  • Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

  • Addimmune, a Clinical Stage Hiv-Focused Gene Therapy Company, to go Public Through Business Combination With 10x Capital Venture Acquisition Corp. III